AbbVie (ABBV) Reports Resolution of HUMIRA Patent Disputes with Amgen (AMGN)
Tweet Send to a Friend
AbbVie (NYSE: ABBV) announced today a global resolution of all intellectual property-related litigation with Amgen (Nasdaq: AMGN) over Amgen's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
